Endocrine oncology

Machine learning algorithms are comparable to conventional regression models in predicting distant metastasis of follicular thyroid carcinoma

Clin Endocrinol (Oxf)Published Retrospective cohort study

Authors' conclusion

The XGBoost approach was comparable to the conventional LR method for predicting the risk of distant metastasis for FTC.

Study context

Population
Patients with newly diagnosed follicular thyroid carcinoma (FTC) in the Surveillance, Epidemiology, and End Results (SEER) database, 2004–2015; 214 (3.68%) with distant metastasis
Participants
5,809 patients
Exposure
XGBoost machine learning (ML) model vs conventional binary logistic regression (LR) model for predicting distant metastasis
Outcome
AUROC for predicting distant metastasis
Methodological detailsSEER database 2004–2015, prediction model development, 10-fold cross-validation
  • SEER database 2004–2015
  • Prediction model development
  • 10-fold cross-validation

Main finding

As reported in the abstract

AUROC for predicting distant metastasis, after 10-fold cross-validation
GroupValueArea under the receiver-operating characteristic (AUROC)
XGBoost0.855 (95% CI 0.803–0.906)0.855
LR0.845 (95% CI 0.818–0.873)0.845

Value

XGBoost0.855 (95% CI 0.803–0.906)
LR0.845 (95% CI 0.818–0.873)

Area under the receiver-operating characteristic (AUROC)

XGBoost0.855
LR0.845

Observational data: associations, not effects.

Further findings

OutcomeXGBoost
AUROC of seven ML algorithms in the test set
AUROC0.836
AUROC of seven ML algorithms in the test set — AUROCs of the seven ML algorithms
0.746-0.836

AUROC of seven ML algorithms in the test set

XGBoost had the best prediction performance

Original publication

Machine learning algorithms are comparable to conventional regression models in predicting distant metastasis of follicular thyroid carcinoma. Clin Endocrinol (Oxf). Published 25 February 2022. doi:10.1111/cen.14693

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.